ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 61 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497,502 | -15.6% | 331,668 | -10.5% | 0.30% | -8.1% |
| Q2 2023 | $589,386 | +175.2% | 370,683 | +24.2% | 0.32% | +208.7% |
| Q1 2023 | $214,187 | +23.8% | 298,560 | 0.0% | 0.10% | +2.0% |
| Q4 2022 | $173,016 | -39.1% | 298,560 | 0.0% | 0.10% | -41.4% |
| Q3 2022 | $284,000 | -33.2% | 298,560 | +20.0% | 0.17% | -30.4% |
| Q2 2022 | $425,000 | – | 248,800 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 5,068,233 | $17,739,000 | 5.88% |
| Sonic Fund II, L.P. | 6,552,068 | $22,932,000 | 1.69% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $1,680,000 | 0.88% |
| Avoro Capital Advisors LLC | 6,950,000 | $24,325,000 | 0.42% |
| RTW INVESTMENTS, LP | 7,357,917 | $25,753,000 | 0.39% |
| K2 PRINCIPAL FUND, L.P. | 898,307 | $3,144,000 | 0.26% |
| Artal Group S.A. | 3,000,000 | $10,500,000 | 0.21% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,827,000 | $9,895,000 | 0.18% |
| WS MANAGEMENT LLLP | 307,442 | $1,076,000 | 0.11% |
| ALGERT GLOBAL LLC | 82,145 | $288,000 | 0.10% |